Biospectra Tris/Tromethamine — Class II drug recall D-0012-2027
Ongoing recall by BioSpectra, Inc., reported 2026-10-14, distributed in CA. Failed stability specifications
| Recall number | D-0012-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | BioSpectra, Inc., Bangor, PA, United States |
| Recall initiated | 2026-07-29 |
| Classified | 2026-10-06 |
| Reported by FDA | 2026-10-14 |
| Distributed | CA |
| Quantity | 200 kilograms |
| Reason classes | specification failure |
| NDC | 64173-0101-25 |
| Expiration dates | 2028-02-29 |
Product
Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25
Reason for recall
Failed stability specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0012-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.